Aalto
Medical device
Rheumatoid Arthritis patients are required to self-inject medication weekly. Due to the reduced dexterity caused by their condition, patients are often unable to safely self-inject using standard injection devices. Patients risk injury and inaccurate dosing because injections cannot be administered effectively. The Aalto concept is an electro-mechanical autoinjector that is designed specifically for use by patients with reduced dexterity. By automating sections of the injection process such as medication loading and needle assembly, user steps that previously had the potential to cause harm now happen within the device to keep patients safe.
Development Time
up to 12 months
Target Regions
Australia / Oceania, Europe, North America
Target Groups
Consumer / User